LICENSE: This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.


101576624
39912
Wiley Interdiscip Rev Dev Biol
Wiley Interdiscip Rev Dev Biol
Wiley interdisciplinary reviews. Developmental biology
1759-7684
1759-7692

27258392
4911333
10.1002/wdev.234
NIHMS767113
Article
Physiological, Pathological, and Engineered Cell Identity Reprogramming in the Central Nervous System
Smith Derek K. 12
Wang Leilei 12
Zhang Chun-Li 12*
1 Department of Molecular Biology, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, Texas 75390, U.S.A., Phone: (214) 648-1670, Fax: (214) 648-1488
2 Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, Texas 75390, U.S.A., Phone: (214) 648-1670, Fax: (214) 648-1488
* Denotes corresponding author
12 3 2016
03 6 2016
7 2016
01 7 2017
5 4 499517
This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.
Multipotent neural stem cells persist in restricted regions of the adult mammalian central nervous system. These proliferative cells differentiate into diverse neuron subtypes to maintain neural homeostasis. This endogenous process can be reprogrammed as a compensatory response to physiological cues, traumatic injury, and neurodegeneration. In addition to innate neurogenesis, recent research has demonstrated that new neurons can be engineered via cell identity reprogramming in non-neurogenic regions of the adult central nervous system. A comprehensive understanding of these reprogramming mechanisms will be essential to the development of therapeutic neural regeneration strategies that aim to improve functional recovery after injury and neurodegeneration.


Introduction

Multipotent neural stem cells (NSC) shape the architecture of early neural networks using molecular patterning cues to control neurogenesis and differentiation. This process rapidly generates billions of neurons, but continues only in discrete areas of the adult mammalian central nervous system. Although tightly regulated by genetic and epigenetic factors, lineage-specific NSC differentiation can be significantly influenced by environmental and pathological cues.

Adult neurogenesis is critical to homeostatic maintenance in neural tissues. However, the small populations of neurons generated by endogenous NSC pools in response to traumatic injury or disease-related neurodegeneration are not sufficient to regenerate functional neural circuits. Therefore, engineered methods for in vitro somatic cell and in vivo glial cell reprogramming are being investigated as potential approaches to neural network reconstruction. These engineered reprogramming methodologies have enabled researchers to investigate neurodegenerative diseases and the mechanisms of neural differentiation in specific disease-relevant genetic models.

Overall, neural reprogramming processes in the adult central nervous system regulate homeostatic maintenance of neural networks, promote degeneration-responsive neural repair, and inspired the development of in vitro disease models and engineered therapeutics.

ADULT NEUROGENESIS OVERVIEW

Neurogenesis in the adult brain

As the central nervous system matures, neurogenesis becomes restricted to localized regions of the adult mammalian brain. The subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) of the lateral ventricle retain NSCs with the ability to proliferate and differentiate into diverse glial and neuronal lineages throughout adulthood (Figure 1)1-6.

The SGZ is located at the interface of the granule cell layer and the hilus of the dentate gyrus. Here, slow-dividing glial fibrillary acidic protein (GFAP)- and nestin (NES)-positive radial glia-like NSCs (type 1 cells) give rise to non-radial precursor cells (type 2A and type 2B cells)7-9. These transiently amplifying type 2B precursor cells become neuroblasts that ultimately differentiate and mature into functional neurons10-13. SGZ neuroblasts adopt glutamatergic granule neuron identity and a small population exhibit GABAergic identity10, 13.

The SVZ is a neurogenic region lining the lateral ventricle that harbours the largest population of proliferating cells in the adult brain14-17. Independent of SGZ neurogenesis, quiescent NSCs (type B cells) become activated and produce fast-dividing multipotent progenitors (type C cells), which ultimately give rise to neuroblasts (type A cells)18-20. These neuroblasts migrate through the rostral migratory stream into the olfactory bulb and predominantly differentiate into GABA-positive granule cells21-24.

In addition to the localized SGZ and SVZ niches, adult neurogenesis has been reported in the amygdala25, cerebellum26, 27, hypothalamus28, substantia nigra29, and various other brain regions. Consistent detection of stem cell populations in these adult brain regions has proven challenging30. Importantly, an examination of markers for DNA replication and neuronal differentiation in human post-mortem neural tissues confirmed that neurogenesis similarly persists in discrete regions of the adult human brain6, 31.

Neurogenesis in the adult spinal cord

Unlike the adult brain, it is unclear whether the adult spinal cord maintains neurogenesis into adulthood. Cells isolated from adult spinal tissue retain certain NSC hallmarks and exhibit multi-lineage differentiation in vitro32; however, these proliferating progenitors exclusively generate glial cells in vivo33. DCX-positive cells, a marker for neural precursor cells, immature neurons, certain reactive glial cells, and dorsal root ganglion sensory neurons34, were reported in dorsal spinal cord. However, these cells do not develop into mature TUBB3-positive or RBFOX3-positive neurons under physiological conditions35. This suggests DCX might not be an effective stand-alone marker for neurogenesis. Furthermore, multiple related studies have failed to detect adult-born neurons in the developed spinal cord33, 36, 37.

PHYSIOLOGICAL NEURAL REPROGRAMMING

Plasticity of adult neurogenesis

Diverse environmental stimuli and endogenous signalling cues modulate the rate of adult neurogenesis in the SGZ and SVZ. This plasticity has been associated with changes in behaviour, motor function, and the onset of neurodegenerative disease (Table 1).

The rate of neurogenesis in the SGZ of adult female rats occurs at a higher rate than in male counterparts. Ovariectomy and bromodeoxyuridine incorporation collectively implicated ovarian hormone production as a causative factor in this gender-specific difference in the rate of neurogenesis38. Increased corticosteroid production in both aging male and female mice also reduces the total population of proliferating neural progenitors in the SGZ and SVZ39-41. In addition to these gender-specific and age-related mechanisms, physical exercise has been implicated in the proliferation rate and survival of SGZ neural cells42. Exercise-induced increases in SGZ neurogenesis are present during periods of activity, but return to a basal rate during rest periods42.

Energetic and hormonal homeostasis is a complex whole-organism process directly influenced by circadian rhythm and sleep duration. Prolonged sleep deprivation negatively affects SGZ neural progenitor proliferation, survival, maturation, and differentiation suggesting an important role for sleep in the regulation of adult hippocampal neurogenesis43, 44. Interestingly, short periods of sleep deprivation do not seem to impact SGZ neurogenesis45 and appear to temporarily increase cell proliferation by accelerating the cell cycle46. Similar to prolonged periods of sleep deprivation, mouse models of physical and psychological stress indicate external environmental stressors negatively affect the production of adult born neurons47, 48.

Neuron identity and neurotransmitter switching

Neuronal subtype is often designated based on neurotransmitter synthesis and characteristic electrical properties. However, throughout early development, immature neurons often switch between the production of excitatory and inhibitory neurotransmitters49. Functional maturation eventually biases neurons toward a principal neurotransmitter that defines the lineage-specific identity of each particular neuron49.

The acquisition of lineage-specific identity does not irreversibly lock interneurons of the rat hypothalamus into exclusively dopamine- or somatostatin-positive fates. Alterations in day length, short- or long-day photoperiods, drive changes in the expression of postsynaptic dopamine receptor expression, but do not affect somatostatin receptor expression50. Pharmacological inhibition of identity-switching dopaminergic neuron activity increased anxiety and depression phenotypes50. Exposure to long-day photoperiods phenocopied this pharmacological inhibition and short-day photoperiods rescued these behavioural phenotypes50. These interesting findings suggest that environmental stimuli directly influence behaviour via neurotransmitter responsivity50.

PATHOLOGICAL NEURAL REPROGRAMMING

The complexity of neuronal networks in the adult brain and spinal cord affords the mammalian nervous system an unparalleled level of cellular communication and information processing. Disruptions in this interconnected network by traumatic injury or degeneration often impart detrimental functional loss. Although neuronal death is one consequence of these destructive events, endogenous NSCs and progenitor cells respond through reparative mechanisms that synergize with reactive gliosis and glial scar formation to promote neural repair (Table 2).

Traumatic neural injury

Neurogenesis induced by traumatic brain injury

Traumatic brain injury activates the proliferation of endogenous neural progenitors. These cells migrate into the hippocampus, differentiate into neurons, and functionally integrate into local brain circuitry in an attempt to regenerate disrupted neuronal networks51. Intraventricular infusion of epidermal growth factor and fibroblast growth factor 2 after ischemic brain injury promotes this production of adult-born neurons51. Adult rodent models exhibit significant increases in SGZ and SVZ neurogenesis in response to traumatic brain injury with proliferation and migration of neural progenitors playing a critical role in functional recovery52, 53.

In addition to changes in neurogenesis, striatal astrocytes have been shown to reprogram following transient middle cerebral artery occlusion54. A subpopulation of striatal astrocytes traced by GFAP-driven green fluorescent protein adopted a PAX6- and NES-positive progenitor state within one week of injury54. These cells expressed the mature neuron markers TUBB3, RBFOX3, and MAP2 within two weeks, as well as, specific markers of cholinergic or GABAergic identity54. In response to stroke injury, SVZ NSCs give rise to a subpopulation of cortical reactive astrocytes that can be induced to adopt neuronal identity via forced in vivo overexpression of Ascl155.

Interestingly, the inhibition of Notch signalling in the absence of injury is also sufficient to reprogram striatal astrocytes into functional neurons56. These Notch signalling pathways are integral to brain injury-response mechanisms and instruct quiescent ependymal cells lining the lateral ventricles to generate neuroblasts and astrocytes in response to acute injury57.

Neurogenesis induced by spinal cord injury

Neural progenitor cells migrate into regions of neural damage following traumatic spinal cord injury58-60. These Nes-LacZ and bromodeoxyuridine-traced cells co-localize with TUBB3 and RBFOX3 indicating that active neurogenesis might have a reparative role in injury-induced neuronal dysfunction events61.

Proliferative ependymal cells lining the central canal were first discovered in a funiculus incision model of spinal cord injury58. Dil pre-labelling was used to trace proliferating ependymal-derived cells to injury sites and revealed these cells primarily differentiate into scar-forming astrocytes58. Furthermore, Dil-labelled ependymal cells generated RBFOX3-positive neuron-like cells with functional properties resembling immature neurons in an experimental model of autoimmune encephalomyelitis62. Nes-CreER or FoxJ1-CreER genetic tracing mouse lines revealed that migrating ependymal cells also differentiate into astrocytes and myelinating oligodendrocytes63.

NG2 cells are another progenitor-like cell population in the adult spinal cord64. These injury-responsive cells rapidly proliferate in response to injury. When transduced with retrovirus encoding NG2 promoter-driven green fluorescent protein, these proliferative cells gave rise to glial scar-forming astrocytes and myelin-producing oligodendrocytes following injury59. When dissociated and cultured in vitro, NG2 cells isolated from spinal cord injury models retained the potential to form neurospheres differentiable to astrocyte, neuron, and oligodendrocyte fates65. Furthermore, these cells produce a small population of HuC/D and MAP2-positive immature neurons65. The production, survival, and maturation of these neurons can be significantly enhanced by retroviral expression of NEUROG2 or exposure to growth factors65.

The meninges of the spinal cord retain a third population of cells that exhibit progenitor-like properties following spinal cord injury60. The proliferation rate and population size of NES-DCX double-positive cells increases in meninges following injury60. Lentiviral labelling of these migratory cells revealed populations in the spinal cord parenchyma and glial scars60. Recent work utilizing Glast-CreER transgenic mice demonstrated that scar-forming stromal cells arise from a pericyte subpopulation and inhibition of this process negatively affects glial scar formation66.

These studies clearly demonstrate a role for neural reprogramming in the injured adult spinal cord and highlight the innate ability of multiple cell types to dedifferentiate, proliferate, and produce scar-forming glial cells (Figure 2). However, lesion-induced spinal neurogenesis is an extremely rare event and in most injury models this process is not observed36, 58, 64.

Neurodegenerative disease

Alzheimer disease

Alzheimer disease is an age-related neurodegenerative disease that impairs cognition, reduces memory recall, and disrupts activities of daily living67, 68. In an adult mouse model of Alzheimer disease, the accumulation of amyloid-beta plaques within the dentate gyrus correlated with reductions in neurogenesis and neural proliferation69, 70. Importantly, this observed decline in proliferation has not been uniformly observed in all Alzheimer disease studies69-71.

Genome-wide association studies identified APOE4 as a predictor of Alzheimer disease onset. APOE4 knockout mice exhibit deficits in SGZ neurogenesis and neural precursor cells become biased toward rapid glial differentiation72. This may result from imbalanced intrahippocampal neurotransmitter release73. Specifically, amyloid-beta aggregation might preferentially induce GABAergic neurotransmission relative to glutamatergic signalling in human amyloid precursor protein transgenic mice and disrupt mechanisms that regulate neurogenesis in the Alzheimer disease brain74. Furthermore, adult born granule cells in this model exhibit impaired morphological and functional maturation suggesting deficits in neurogenesis accompany Alzheimer disease onset74.

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by the degeneration of motor neurons resident to the motor cortex, brain stem, and spinal cord75. The progressive degeneration of these neurons triggers fasciculation, hyperreflexia, and a reduced ability to initiate voluntary movement75.

Cellular tracing of spinal neural precursor cells in a rodent model of ALS was achieved using NES promoter-regulated reporter expression in SOD1-G93A transgenic mice61. These neural precursors, derived from the ependymal zone surrounding the central canal, increased both proliferation rate and migration in response to motor neuron degeneration61. However, these cells lost proliferation potential upon migration, which limited the total number of reparative cells relocated to sites of degeneration61. These precursor cells migrated into the dorsal and ventral horn regions of the spinal cord following ALS onset. Importantly, disease onset increased de novo neurogenesis and enhancement of this process might be beneficial to the development of ALS therapies61.

Huntington disease

Huntington disease is an autosomal dominant genetic disorder that results in progressive loss of striatal medium spiny neurons76, 77. This degeneration manifests as deficits of motor coordination, physical instability, involuntary movement, emotional outbursts, and cognitive impairment76. Huntington disease-afflicted individuals exhibit increased subventricular cell division78 and TUBB3-positive neural precursor cells near the caudate nucleus79. In parallel with these findings, migratory striatum-bound neuroblasts were observed in transgenic mice that model rapid Huntington disease onset and disease progression80, 81. Cellular tracing revealed these cells originate in the SVZ31; however, these neuroblasts were surprisingly unable to differentiate into functional neurons after relocation into the striatum80, 81. Interestingly, mouse models of slow progressing Huntington disease exhibit reduced SGZ neural proliferation82, 83, while SVZ proliferation remains relatively unchanged31, 78-81.

Multiple sclerosis

Multiple sclerosis is a neuroinflammatory disease characterized by axon degeneration, demyelination, neural inflammation, and acquired neurological dysfunction84, 85. Experimental models of autoimmune encephalomyelitis revealed that DiI-labelled ependymal cells proliferate and migrate into areas of inflammation62. These relocated cells then differentiate into TUBB3-positive, RBFOX3-positive neuron-like cells62. Whole-cell patch-clamp recordings from freshly isolated DiI-labelled cells demonstrated that these cells fire action potentials with properties similar to immature neurons62. This work demonstrated the first evidence that neurogenesis might occur in neuroinflammatory lesions within the adult spinal cord62.

Parkinson disease

Parkinson disease is an adult-onset chronic neurodegenerative disorder characterized by bradykinesia, gait disturbance, resting tremor, and rigidity86. Deficits in motor function are primarily the result of dopaminergic neuron death in the substantia nigra and, in later stages, the basal forebrain and cortex87. Individuals diagnosed with Parkinson disease generally exhibit deficits of neural proliferation in the SVZ evidenced by a reduction in post-mortem staining of proliferating cell nuclear antigen88.

Reduced dopaminergic innervation in animal models of Parkinson disease might lead to deficits in dopaminergic signalling pathways with governing roles in the regulation of SVZ neural proliferation89-94. However, contrary immunocytochemical analyses of proliferation markers in the Parkinson disease-afflicted brain suggest dopaminergic neuron death does not directly contribute to reduced neural proliferation following disease onset95. Although a consensus has not yet emerged on the severity of impact that dopaminergic neuron death has on neuroproliferation in the adult brain, reductions in olfactory bulb volume and SGZ neuron populations suggest that Parkinson disease does negatively impact adult neurogenesis89, 90, 96. This reduced neurogenic potential might underlie behavioural symptoms such as depression and impaired logic97.

ENGINEERED NEURAL REPROGRAMMING

Induced pluripotent stem cells

Foundational discoveries: nuclear transfer, teratocarcinoma cells, and embryonic stem cells

Lineage-specific differentiation and cellular identity are a consequence of intracellular signals that modulate transcription. The concept that targeted modification of the transcriptome can be used to engineer cellular identity emerged from early nuclear transfer and pluripotency research. The transplantation of Rana pipens nuclei from blastula cells into oocytes induced pluripotency and revealed that the nucleus dominantly regulates cell identity98. Expanding this work, nuclei from Xenopus laevis epithelial cells were transplanted into enucleated oocytes, which developed into viable embryos99. The remarkable discovery that nuclei from differentiated cells retain a potential to generate functional organisms was highlighted with the birth of lambs from oocytes carrying adult sheep mammary cell nuclei100.

Somatic cell nuclear transfer demonstrated functional pluripotency in vivo; however, in vitro models of pluripotency relied on teratocarcinoma cells derived from murine tumors. The isolation of these stem cell-like cells provided the first in vitro model of pluripotency101. The subcutaneous engraftment of single teratocarcinoma cells into healthy mice resulted in teratoma formation and confirmed that these multipotential cells can differentiate into multiple somatic lineages102. However, this model exhibited limited differentiation potential relative to embryo-derived stem cells.

Breakthrough cell culture techniques next enabled the in vitro isolation of mouse and human embryonic stem cell (ESC) lines, which provided a physiological model of cellular differentiation and lineage specification103-105. Importantly, ESCs engineered to express a Î²-galactosidase reporter contributed to all parts of the central nervous system when implanted into a developing mouse blastocyst106. Moreover, neural lineage-biased ESCs transplanted into the rat brain differentiated into astrocytes, neurons, and oligodendrocytes107. These fundamental investigations into the genetic regulation of pluripotency and neural specification laid the groundwork for somatic cell engineering and reprogramming technologies (Figure 3).

Induced pluripotency

In a discovery that reshaped the definition of terminal differentiation, the viral overexpression of KLF4, MYC, POU5F1, and SOX2 transcription factors induced embryonic and adult mouse fibroblasts to revert into a pluripotent state108. Similarly, these factors were sufficient to reprogram adult human fibroblasts into induced pluripotent stem cells (iPSCs)109. The genetic regulatory mechanisms underlying iPSC reprogramming were teased apart in studies demonstrating three factor induced pluripotency110 and even POU5F1-induced pluripotency under defined conditions111. Providing a direct link between extracellular cues and intracellular transcription, a cocktail of seven chemical compounds was used to induce mouse somatic cells toward a pluripotent fate in vitro112.

The immense therapeutic potential for patient-specific iPSCs and iPSC-derived cell types in neurodegenerative diseases inspired diverse applications to Alzheimer disease, ALS, Huntington disease, multiple sclerosis, and Parkinson disease. Adult human fibroblast-derived iPSCs differentiate into glia and diverse neuronal subtypes when cultured under lineage restrictive conditions108, 113 (Figure 4). The motor neuron-specific differentiation of 16 iPSC lines derived from healthy and ALS-afflicted individuals enabled novel modeling of disease progression and targeted drug discovery114. Specific to Huntington disease, PPP1R1B-positive medium spiny neurons were generated from iPSCs using SHH and DKK1 in combination with bone morphogenetic protein and transforming growth factor-beta inhibitors115. In addition to neurons, glial-specific iPSC differentiation protocols yielded astrocyte progenitors and immature astrocytes116. Although potentially valuable as a source of neural progenitors or differentiated neurons, the direct induction of iPSC cells in vivo results in teratoma formation in multiple organ tissues117. This drawback to induced pluripotency suggests that more restrictive neural progenitor cells might be better suited for therapeutic applications and in vitro modeling of neural differentiation.

Induced neural progenitors

Temporal restriction of POU5F1 expression to the first five days of reprogramming combined with constitutive SOX2, KLF4, and MYC expression converted fibroblasts into neural progenitor-like cells with properties similar to endogenous NSCs118 (Figure 4). The tight regulation of POU5F1 activity is critical as prolonged expression results in the adoption of pluripotent properties. NSC specification was also achieved with an expanded set of transcription factors that included KLF4, MYC, POU3F4, SOX2, and TCF3119. The induction of NSC-like progenitor cells using diverse combinations of proteins, RNAs, and microRNAs highlights how the modulation of protein, RNA, and microRNA expression offers multiple entry points for engineering cellular identity. For instance, FOXG1 and SOX2 are sufficient to induce a bipotent neural precursor identity from mouse fibroblasts120. The co-expression of a third factor, POU3F2, further endows these reprogrammed cells with tripotent differentiation potential120. Strikingly, mouse embryonic fibroblasts, mouse tail-tip fibroblasts, and human urinary cells exposed to valproic acid, CHIR99021, and Repsox under hypoxic culture conditions reprogram into multipotent neural precursors121.

In vivo multipotency

Acquired multipotency enables iPSC-derived neural precursor cells to differentiate into astrocytes, neurons, and oligodendrocytes118. Surprisingly, SOX2 itself is sufficient to impart multipotency in cultured human fibroblasts122. SOX2-transduced fibroblasts directly transform into self-renewing NSCs that form neurospheres and differentiate into mature functional neurons following transplantation into the mouse cortex122.

Independent in vivo studies demonstrated that SOX2-encoding lentivirus transforms striatal astrocytes into neuroblasts poised to differentiate into functional neurons upon treatment with valproic acid123. These reprogrammed astrocytes pass through an ASCL1-dependent progenitor state and require the nuclear receptor TLX for acquisition of neuronal identity124, 125. Closely related work in the spinal cord demonstrated that GFAP promoter-regulated SOX2 overexpression in astrocytes imparts a proliferative, but non-tumorigenic neuroblast identity capable of producing multiple neurons from each reprogrammed astrocyte36 (Figure 2). In an attempt to demonstrate the clinical utility of reprogrammed neurons, iPSC-derived neural progenitor cells were transplanted into a primate model of Parkinson disease126. These cells persisted for at least six months in the neural microenvironment and differentiated into astrocytes, functional neurons, and myelinating oligodendrocytes126. These cell transplantation and in vivo reprogramming studies demonstrate that engineered cells exhibit significant regenerative potential in cases of traumatic neural injury and age-related neurodegeneration (Table 3).

Transdifferentiation

Transdifferentiation factors and neural subtype

The direct induction of functional neurons from mouse fibroblasts by in vitro overexpression of ASCL1, POU3F2, and MYT1L demonstrated a fundamental plasticity in the identity of lineage-committed somatic cells127 (Table 4). The complexity of transcription and dynamic regulation of cell-specific gene sets provide multiple points of entry for targeted cell reprogramming. For instance, certain microRNAs can replace transcription factors to promote neuronal reprogramming of human fibroblasts128, 129,. Surprisingly, activation of small molecule-driven signal transduction pathways is sufficient to transdifferentiate mouse fibroblasts130, human fibroblasts131, and human astrocytes132 into functional neurons. Highlighting the significant roles for signal transduction activators in neural reprogramming, the pro-neural transcription factor NEUROG2 converts human fibroblasts into functional neurons with nearly 90% efficiency only in the presence of forskolin, a cyclic AMP synthesis activator, and dorsomorphin, a bone morphogenic protein type 1 receptor inhibitor133.

The pro-neurogenic properties of NEUROG2 have enabled the induction of neurons from fibroblasts133, as well as, mouse cortical astrocytes134. While fibroblasts specifically differentiated into cholinergic neurons, in vitro reprogrammed cortical astrocytes adopt a glutamatergic identity. This divergence in neuronal subtypes suggests that cell-of-origin identity influences reprogramming potential. In addition to excitatory glutamatergic neurons, DLX2-driven reprogramming generates GABAergic inhibitory neurons from mouse cortical astrocytes134. The precise specification of striatal inhibitory medium spiny neurons from human fibroblasts utilized DLX2 in combination with miR-124, miR-9/9*, MYT1L, BCL11B, and DLX1135. These in vitro generated neurons exhibited action potentials and expressed characteristic GABA, GAD1, and PPP1R1B molecular markers135.

Lineage-specific induction of neurons is critical to the development of disease models and therapeutics. With relevance to Parkinson disease, mouse and human fibroblasts transduced with defined combinations of pro-dopaminergic transcription factors reprogrammed into functional dopaminergic neurons136-140. These induced neurons exhibited mature synaptic properties and neurotransmitter release. Transplantation of these neurons into a 6-hydroxydopamine lesioned rodent model of Parkinson disease modestly improved deficits of motor function137-139.

Parkinson disease and ALS predominantly affect dopaminergic and motor neuron subpopulations, respectively. Expanding on the discovery that ASCL1, POU3F2, and MYT1L drive fibroblast-to-neuron reprogramming, these three pro-neural factors were co-expressed with LHX3, ISL1, MNX1, NEUROG2, and NEUROD1 to generate functional motor neurons in vitro with low efficiency141. When combined with growth factors and small molecules, ISL1, LHX3, NEUROG2, and SOX11 induced functional spinal motor neurons with high efficiency from adult human skin fibroblasts142. These motor neurons formed functional neuromuscular junctions with skeletal myotubes and exhibited disease-specific pathological features when generated from skin fibroblasts of ALS-afflicted individuals. Remarkably, these functional deficits were rescued by exposure to the small molecule kenpaullone during reprogramming142. These findings highlight the potential utility of induced neurons in disease modelling and drug identification.

The ability to directly in vitro transdifferentiate functional subtype-specific neurons from somatic and glial cells has enabled focused investigations into the progression of development and disease. Further, the genetic reprogramming factors and small molecules identified in these screens have guided in vivo neural reprogramming strategies.

In vivo transdifferentiation

To investigate whether somatic cells can be directly converted into neurons in vivo, human fibroblasts and astrocytes engineered to express doxycycline-inducible pro-neural transcription factors were transplanted into the rat striatum143. This precise control over ASCL1, POU3F2, and MYT1L expression enabled transdifferentiation within the neural microenvironment. Both transplanted human fibroblasts and astrocytes reprogrammed into functional, synapse-forming interneurons and exhibited long-term survival post-doxycycline withdrawal. The in vivo application of these findings enabled researchers to directly convert resident non-neuronal glia of the adult mouse striatum into neurons using lentiviral-mediated expression of ASCL1, POU3F2, and MYT1L143.

In parallel, NEUROG2-encoding retrovirus and local administration of growth factors following focal injury were used to induce glutamatergic and GABAergic neurons from non-neuronal cells in the neocortex and striatum, respectively144. This divergence in cell identity suggests that NEUROG2 activates a pro-neural transcriptional program while the neural microenvironment modulates subtype-specific differentiation.

Reactive astrocytes of the mouse cortex rapidly transform into functional neurons when transduced with NEUROD1-encoding retrovirus145. While astrocytes adopted a strictly excitatory glutamatergic identity, NG2 glia converted into heterogeneous populations of glutamatergic and GABAergic interneurons145. Interestingly, reactive astrocytes reprogrammed with higher efficiency in a mouse model of Alzheimer disease than control reactive astrocytes145. Furthermore, alternative strategies have demonstrated the in vivo reprogramming of astrocytes and NG2 glia into neurons using variable combinations of SOX2, ASCL1, LMX1A, and NR4A2146-148.

Similar to the transdifferentiation of adult glia and somatic cells, in vivo reprogramming can be used to influence the lineage-specific differentiation of early postmitotic neurons. The electroporation of neural progenitors that produce GABAergic medium spiny neurons in the lateral ganglionic eminence with the transcription factor FEZF2 resulted in differentiation toward a glutamatergic identity149. Similarly, the in vivo overexpression of FEZF2 in early post-mitotic callosal projection neurons and layer IV interneurons induces glutametergic corticofugal projection neurons149, 150. These studies indicate that individual transcription factors can dictate the subtype-specific development of neurons and the fine-tuned expression of these factors is essential to the production of localized neuron populations in the developing central nervous system (Table 5). While in vitro and in vivo transcriptomic modification can induce functional changes in cellular identity, these cells often retain cell-of-origin genetic hallmarks not acquired during developmental differentiation.

Characterization of engineered cells

Identity: clearance of cell-of-origin identity and induction of lineage-specific neurons

The specification of neurons throughout development relies on stepwise shifts in gene expression that restrict cells to a defined lineage. These shifts in gene expression are tightly controlled by DNA methylation, histone modifications, and regional chromatin condensation. An analysis of global gene expression in ASCL1, POU3F2, and MYT1L reprogrammed neurons demonstrated that, although these pro-neural transcription factors bias the mouse embryonic fibroblast transcriptome toward a neuronal identity, induced neurons do not completely abolish fibroblast-specific gene expression151. Genetic studies using iPSC-derived neurons revealed that reprogramming occurs in waves of transcription accompanied by altered histone acetylation and methylation152.

Transcription is directly activated or repressed by the binding of transcription factors to gene enhancer and promoter regions. The methylation of cytosine nucleotides in these regions can reduce the affinity of DNA binding proteins for these sequences. Genome-wide methylation analysis in somatic cell-derived iPSCs demonstrated that induced pluripotency does not completely reset the genomic methylation signature in reprogrammed cells to remove marks characteristic of the cell of origin138. A detailed understanding of the molecular mechanisms responsible for neural reprogramming will enable further advances in the robust generation of dopaminergic neurons136, medium spiny GABAergic neurons135, cholinergic neurons133, and motor neurons141, 142.

Function: single neuron electrical properties and network integration

Neurotransmitter synthesis, synapse formation, and action potential kinetics are functional properties that characterize how a neuron will integrate and function within the local network. Single-cell electrophysiology demonstrated that fibroblast-derived neurons acquire electrical potential in vitro153. The more complex in vivo conversion of astrocytes to calretinin-positive striatal neurons confirmed that induced neurons functionally integrate directly into the local neuronal network124. Four predominant types of neurons were generated from SOX2-transduced astrocytes and each exhibited unique electrical properties124. This indicates that astrocyte identity and cues within the microenvironment directly impact functional maturation of induced neurons124.

The in vivo generation of neurons from cortical and striatal glia highlights the genetic dominance of pro-neural factors in neural cell identity and maintenance36, 121, 123, 124, 143-146, 148. The outgrowth of axons and dendrites during reprogramming enabled these cells to form synapses with neighboring endogenous neurons. However, whether these neurons meaningfully contribute to the cognitive or motor function remains untested. The transplantation of fibroblast-derived dopaminergic neurons into a mouse model of Parkinson disease demonstrated that reprogrammed neurons not only functionally integrate into local neural networks, but also improve motor coordination recovery following disease onset138. These discoveries demonstrate that transcription factors are master regulators of cell identity and an understanding of the genetic mechanisms regulating neural reprogramming is critically important to the clinical development of these technologies.

Clinical applications: efficiency of neuron production and tumorigenicity

The clinical utility of engineered neurons relies on high efficiency production of neurons with stable identity. However, initial transdifferentiation methods produced neurons with efficiencies under 10% of the starting cell population. Similarly, human fibroblasts transduced with NEUROG2-encoding and SOX11-encoding lentivirus convert with low efficiency; however, exposure to forskolin and dorsomorphin dramatically enhance conversion above 90% efficiency133. This small molecules-based approach might enable large-scale production of transplantable neurons and patient-specific pharmaceutical screening. Another approach to this problem is increasing the total number of reprogrammed neurons that survive into functional maturity. Astrocyte-derived neuroblasts proliferate upon reprogramming and yield multiple neurons that persist in vivo for at least 14 weeks123.

The safe induction of new post-mitotic neurons is another hurdle in the translation of this technology to the clinic. The division of pluripotent stem cells and neural progenitors is regulated by molecular signals that control proliferation to prevent tumor formation. In vivo reprogramming toward an iPSC fate indicates deficits in these mechanisms and results in teratoma formation in multiple organ tissues117. However, the generation of neural-specific progenitors and in vivo transdifferentiation of neurons is not limited by tumorigenicity36, 123, 145. In addition, genome-wide sequencing of iPSC lines uncovered both genetic and epigenetic mutations acquired upon reprogramming that have established roles in cancer progression154. Further refinement of high-efficiency, non-tumorigenic reprogramming protocols will be required for engineered neurons to find breakthrough applications in the clinical setting (Figure 5).

Conclusion

The plasticity of cell identity is modulated throughout the developing and adult central nervous system by environmental, pathological, and therapeutic factors. Physiological changes in neurotransmitter production, neurogenic proliferation post-traumatic injury, and degeneration-induced neurogenesis highlight the dynamic nature of neural identity within the mammalian nervous system. Although limited neurogenesis in the adult brain hinders regeneration following traumatic injury and disease-related degeneration, state-of-the-art engineered neuronal reprogramming methods might enable the transplantation or in vivo generation of new functional neurons within the human nervous system. As an early-stage biomedical technology, neuronal reprogramming currently faces numerous challenges that limit clinical utility. As constraints to reprogramming efficiency, factor delivery, and safety are overcome, we believe neuronal engineering will offer a new paradigm in patient-specific neural regeneration.

Funding sources: C.-L. Zhang is a W. W. Caruth Jr. Scholar in Biomedical Research. Research in the Zhang laboratory is supported by The Decherd Foundation, The Michael J. Fox Foundation, The National Institutes of Health (NS070981, NS088095, and NS093502), The Texas Institute for Brain Injury and Repair, and The Welch Foundation (I-1724).

Figure 1 Neurogenesis in the adult brain

The subgranular zone (SGZ) of the dentate gyrus and subventricular zone (SVZ) of the lateral ventricle (LV) retain the capacity for neurogenesis into adulthood. SGZ NSCs (type 1 cells) generate non-radial precursor (type 2) cells, which proliferate and develop into neuroblasts and ultimately differentiated granule neurons within the dentate gyrus. By contrast, active SVZ NSCs (type B cells) first generate fast-dividing transit amplifying progenitor (type C) cells, convert into neuroblasts, and migrate through the rostral migratory stream (RMS) into the olfactory bulb (OB) for differentiation into GABA-positive olfactory neurons. EP, ependymal cells; GCL, granule cell layer; ML, molecular layer.

Figure 2 Neural reprogramming in the adult spinal cord

Multiple cell types in the adult spinal cord reprogram in response to injury or engineered stimuli. In response to traumatic injury or neuroinflammation, resident spinal cells dedifferentiate, proliferate, and produce multiple glial lineages. However, the existence of endogenous lesion-induced neurogenesis remains debated. The in vivo generation of mature neurons has been achieved using both neuroblast-based and direct reprogramming strategies.

Figure 3 Historical timeline of pluripotency research

This timeline highlights eleven milestone events that defined our understanding of developmental and engineered pluripotency.

Figure 4 Engineered cell identity reprogramming

Cell identity can be engineered using pluripotency-based, progenitor-based or transdifferentiation strategies. Pluripotency-based reprogramming strategies involve the dedifferentiation of a somatic cell and re-specification of the desired cell type from the resultant iPSC. Progenitor-based reprogramming converts a somatic cell into an expandable neural progenitor that further differentiates into the desired neural lineage. Transdifferentiation enables the direct generation of functional neurons from differentiated non-neuronal cell types.

Figure 5 Clinical barriers to engineered reprogramming

Numerous safety- and efficacy-related hurdles have hindered the clinical application of neural reprogramming technologies. Viral-based gene delivery, limited success of in vivo genetic correction technologies, iPSC tumorigenicity, and high-efficiency production of functional neurons with homogenous identity have limited the utility of reprogramming technologies in the clinic. Solutions to these issues such as small molecule-based reprogramming and in vivo transdifferentiation are currently under development.

Table 1 Physiological effectors of neurogenesis and innate reprogramming

Physiological effectors	Change in Neurogenesis	
	
	SGZ	SVZ	
Aging	Decrease 39-41	Decrease39-41	
Long-Period Sleep Deprivation	Decrease44		
Short-Period Sleep Deprivation	Increase45, 46		
Ovarian Hormone Production	Increase38		
Physical and Psychosocial Stress	Decrease47, 48		
Physical Exercise	Increase42		

Table 2 Pathological effectors of neurogenesis and innate reprogramming

Pathological Effector	Change in Neurogenesis	
	
	SGZ	SVZ	
Alzheimer Disease	Increase and Decrease69, 70		
Huntington Disease	Decrease82, 83	Increase78, 79	
Parkinson Disease	Decrease89-94	Decrease89, 90, 96	
Traumatic Brain Injury and Stroke	Increase51	Increase52	
	
Amyotrophic Lateral Sclerosis	Enhanced Spinal Cord Neurogenesis61	
Multiple Sclerosis	Spinal Cord Neurogenesis62	

Table 3 Engineered reprogramming: in vivo and in vitro induction and differentiation of neural progenitors

Species	Origin Identity	Engineered Identity	Reprogramming Factors	
Mouse a, in vivo	Spinal Astrocyte	Neuroblast36	SOX2	
Mouse a, in vivo	Striatal Astrocyte	Neuroblast123-125	SOX2	
	
Mouse e, in vitro	Fibroblast	Bipotent NPC120	FOXG1, SOX2	
Mouse e, in vitro	Fibroblast	Tripotent NPC120	FOXG1, POU3F2, SOX2	
Mouse e, in vitro	Fibroblast	Tripotent NPC121	CHIR99021, Repsox, Valproic Acid	
Human u, in vitro	Urinary Cell	Tripotent NPC121	CHIR99021, Repsox, Valproic Acid	
	
Human f, in vitro	Fibroblast	NSC122	SOX2	
Mouse e, in vitro	Fibroblast	NSC122	SOX2	
Mouse e, in vitro	Fibroblast	NSC118	KLF4, MYC, POU5F1, SOX2	
Mouse e, in vitro	Fibroblast	NSC119	KLF4, MYC, POU3F4, SOX2, TCF3	
Note: If known, the developmental stage of cell origin is indicated.

a adult

e embryonic

f fetal

u unknown.

Table 4 Engineered reprogramming: in vitro transdifferentiation

Species	Origin Identity	Engineered Identity	Reprogramming Factors	
Human a	Cortical Astrocyte	Neuron132	Nine small molecules	
Human a	Fibroblast	Neuron128	miR-124, MYT1L, POU3F2	
Human p,a	Fibroblast	Neuron129	ASCL1, miR-9/9*, miR-124, NEUROD2, MYT1L	
Human a	Fibroblast	Neuron131	Seven small molecules	
Mouse e	Fibroblast	Neuron130	CHIR99021, Forskolin, ISX9, SB431542	
Mouse e	Fibroblast	Neuron127	ASCL1, MYT1L, POU3F2	
	
Human f	Fibroblast	Cholinergic Neuron133	Dorsomorphin, Forskolin, NEUROG2	
Human a	Fibroblast	Cholinergic Neuron133	Dorsomorphin, Forskolin, FGF2, NEUROG2, SOX11	
Human e, p	Fibroblast	Dopaminergic Neuron136	ASCL1, FOXA2, LMX1A, MYT1L, POU3F2	
Mouse e,a
Human f,a	Fibroblasts	Dopaminergic Neurons137	ASCL1, LMX1A, NR4A2	
Mouse a	Fibroblasts	Dopaminergic Neurons138	ASCL1, EN1, FGF8, FOXA2, LMX1A, NR4A2, PITX3, SHH	
Human f	Fibroblasts	Dopaminergic Neurons139	ASCL1, NEUROG2, NR4A2, PITX3, SOX2	
Mouse e
Mouse p	Fibroblasts
Astrocytes	Dopaminergic Neurons140	ASCL1, LMX1B, NR4A2	
Mouse p	Cortical Astrocyte	GABAergic Neuron134	DLX2	
Mouse p	Cortical NG2 Cell	GABAergic and Glutamatergic Neurons145	NEUROD1	
Human
Mouse p	Cortical Astrocyte	Glutamatergic Neuron145	NEUROD1	
Mouse p	Cortical Astrocyte	Glutamatergic Neuron134	NEUROG2	
Human e
Mouse e	Fibroblast	Motor Neuron141	ASCL1, ISL1, LHX3, MNX1, MYT1L, NEUROD1, NEUROG2, POU3F2	
Human a	Fibroblasts	Motor Neuron142	Dorsomorphin, Forskolin, FGF2, NEUROG2, SOX11, ISL1, LHX3	
Human p	Fibroblast	Striatal Medium Spiny Neuron135	BCL11B, DLX1, DLX2, miR-9/9*, miR-124, MYT1L	
Note: If known, the developmental stage of cell origin is indicated.

a adult

e embryonic

f fetal

p early postnatal.

Table 5 Engineered reprogramming: in vivo transdifferentiation

Species	Origin Identity	Engineered Identity	Reprogramming Factors	
Mouse p, a	Cortical Astrocyte	GABAergic and Glutamatergic Neurons148	ASCL1	
Mouse a	Cortical Astrocyte	Glutamatergic neuron145	NEUROD1	
Mouse a	Spinal Astrocyte	GABAergic and Glutamatergic Neurons36	SOX2, Valproic Acid	
Mouse a	Striatal Astrocyte	Calretinin Neuron123, 124	SOX2, Valproic Acid	
Mouse a	Striatal Astrocyte	Neuron143	ASCL1, MYT1L, POU3F2	
	
Mouse a	Cortical NG2 Cell	GABAergic and Glutamatergic Neurons145	NEUROD1	
Mouse a	Cortical NG2 Cell	Neuron146	SOX2	
Mouse a	Striatal NG2 Cell	GABAergic and Glutamatergic Neurons147	ASCL1, LMX1A, NURR1	
	
Mouse a	Non-Neuronal Cell	GABAergic and Glutamatergic Neurons144	EGF, FGF2, NEUROG2	
	
Mouse p	LGE Neural Progenitor	Cortical Projection Neuron149	FEZF2	
Mouse a	Spinal Neural Progenitor	GABAergic neuron65	BDNF, EGF, FGF2, NEUROG2	
	
Mouse e, p	Callosal Projection Neuron	Glutamatergic Corticofugal Projection Neuron155	FEZF2	
Mouse p	Spiny Neuron	Pyramidal Neuron150	FEZF2	
Note: If known, the developmental stage of cell origin is indicated.

a adult

e embryonic

p early postnatal.

Disclosures and conflicts of interest: None declared


References

1 Altman J Are new neurons formed in the brains of adult mammals? Science 1962 135 1127 1128 13860748
2 Altman J Das GD Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965 124 319 335 5861717
3 Kaplan MS Hinds JW Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science 1977 197 1092 1094 887941
4 Lois C Garcia-Verdugo JM Alvarez-Buylla A Chain migration of neuronal precursors. Science 1996 271 978 981 8584933
5 Gage FH Coates PW Palmer TD Kuhn HG Fisher LJ Suhonen JO Peterson DA Suhr ST Ray J Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A 1995 92 11879 11883 8524867
6 Eriksson PS Perfilieva E Bjork-Eriksson T Alborn AM Nordborg C Peterson DA Gage FH Neurogenesis in the adult human hippocampus. Nat Med 1998 4 1313 1317 9809557
7 Filippov V Kronenberg G Pivneva T Reuter K Steiner B Wang LP Yamaguchi M Kettenmann H Kempermann G Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes. Mol Cell Neurosci 2003 23 373 382 12837622
8 Fukuda S Kato F Tozuka Y Yamaguchi M Miyamoto Y Hisatsune T Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J Neurosci 2003 23 9357 9366 14561863
9 Kronenberg G Reuter K Steiner B Brandt MD Jessberger S Yamaguchi M Kempermann G Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli. J Comp Neurol 2003 467 455 463 14624480
10 Cameron HA McKay RD Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 2001 435 406 417 11406822
11 Brown JP Couillard-Despres S Cooper-Kuhn CM Winkler J Aigner L Kuhn HG Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 2003 467 1 10 14574675
12 Brandt MD Jessberger S Steiner B Kronenberg G Reuter K Bick-Sander A von der Behrens W Kempermann G Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci 2003 24 603 613 14664811
13 Liu S Wang J Zhu D Fu Y Lukowiak K Lu YM Generation of functional inhibitory neurons in the adult rat hippocampus. J Neurosci 2003 23 732 736 12574400
14 Altman J Autoradiographic investigation of cell proliferation in the brains of rats and cats. Anat Rec 1963 145 573 591 14012334
15 Privat A Leblond CP The subependymal layer and neighboring region in the brain of the young rat. J Comp Neurol 1972 146 277 302 5086674
16 Morshead CM van der Kooy D Postmitotic death is the fate of constitutively proliferating cells in the subependymal layer of the adult mouse brain. J Neurosci 1992 12 249 256 1729437
17 Morshead CM Reynolds BA Craig CG McBurney MW Staines WA Morassutti D Weiss S van der Kooy D Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994 13 1071 1082 7946346
18 Doetsch F Garcia-Verdugo JM Alvarez-Buylla A Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 1997 17 5046 5061 9185542
19 Doetsch F Garcia-Verdugo JM Alvarez-Buylla A Regeneration of a germinal layer in the adult mammalian brain. Proc Natl Acad Sci U S A 1999 96 11619 11624 10500226
20 Garcia-Verdugo JM Doetsch F Wichterle H Lim DA Alvarez-Buylla A Architecture and cell types of the adult subventricular zone: in search of the stem cells. J Neurobiol 1998 36 234 248 9712307
21 Luskin MB Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993 11 173 189 8338665
22 Lois C Alvarez-Buylla A Long-distance neuronal migration in the adult mammalian brain. Science 1994 264 1145 1148 8178174
23 Carleton A Petreanu LT Lansford R Alvarez-Buylla A Lledo PM Becoming a new neuron in the adult olfactory bulb. Nat Neurosci 2003 6 507 518 12704391
24 Belluzzi O Benedusi M Ackman J LoTurco JJ Electrophysiological differentiation of new neurons in the olfactory bulb. J Neurosci 2003 23 10411 10418 14614100
25 Bernier PJ Bedard A Vinet J Levesque M Parent A Newly generated neurons in the amygdala and adjoining cortex of adult primates. Proc Natl Acad Sci U S A 2002 99 11464 11469 12177450
26 Klein C Butt SJ Machold RP Johnson JE Fishell G Cerebellum- and forebrain-derived stem cells possess intrinsic regional character. Development 2005 132 4497 4508 16162650
27 Lee A Kessler JD Read TA Kaiser C Corbeil D Huttner WB Johnson JE Wechsler-Reya RJ Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005 8 723 729 15908947
28 Kokoeva MV Yin H Flier JS Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science 2005 310 679 683 16254185
29 Zhao M Momma S Delfani K Carlen M Cassidy RM Johansson CB Brismar H Shupliakov O Frisen J Janson AM Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 2003 100 7925 7930 12792021
30 Gould E How widespread is adult neurogenesis in mammals? Nat Rev Neurosci 2007 8 481 488 17514200
31 Ernst A Alkass K Bernard S Salehpour M Perl S Tisdale J Possnert G Druid H Frisen J Neurogenesis in the striatum of the adult human brain. Cell 2014 156 1072 1083 24561062
32 Shihabuddin LS Horner PJ Ray J Gage FH Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 2000 20 8727 8735 11102479
33 Horner PJ Power AE Kempermann G Kuhn HG Palmer TD Winkler J Thal LJ Gage FH Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000 20 2218 2228 10704497
34 Dellarole A Grilli M Adult dorsal root ganglia sensory neurons express the early neuronal fate marker doublecortin. J Comp Neurol 2008 511 318 328 18803236
35 Shechter R Ziv Y Schwartz M New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cord. Stem Cells 2007 25 2277 2282 17540856
36 Su Z Niu W Liu ML Zou Y Zhang CL In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun 2014 5 3338 24569435
37 Juhasova J Juhas S Hruska-Plochan M Dolezalova D Holubova M Strnadel J Marsala S Motlik J Marsala M Time course of spinal doublecortin expression in developing rat and porcine spinal cord: implication in in vivo neural precursor grafting studies. Cell Mol Neurobiol 2015 35 57 70 25487013
38 Tanapat P Hastings NB Reeves AJ Gould E Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci 1999 19 5792 5801 10407020
39 Kuhn HG Dickinson-Anson H Gage FH Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996 16 2027 2033 8604047
40 Jin K Sun Y Xie L Batteur S Mao XO Smelick C Logvinova A Greenberg DA Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2003 2 175 183 12882410
41 Enwere E Shingo T Gregg C Fujikawa H Ohta S Weiss S Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. J Neurosci 2004 24 8354 8365 15385618
42 van der Borght K Ferrari F Klauke K Roman V Havekes R Sgoifo A van der Zee EA Meerlo P Hippocampal cell proliferation across the day: increase by running wheel activity, but no effect of sleep and wakefulness. Behav Brain Res 2006 167 36 41 16214238
43 Mirescu C Peters JD Noiman L Gould E Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proc Natl Acad Sci U S A 2006 103 19170 19175 17135354
44 Fernandes C Rocha NB Rocha S Herrera-Solis A Salas-Pacheco J Garcia-Garcia F Murillo-Rodriguez E Yuan TF Machado S Arias-Carrion O Detrimental role of prolonged sleep deprivation on adult neurogenesis. Front Cell Neurosci 2015 9 140 25926773
45 Roman V Van der Borght K Leemburg SA Van der Zee EA Meerlo P Sleep restriction by forced activity reduces hippocampal cell proliferation. Brain Res 2005 1065 53 59 16309630
46 Junek A Rusak B Semba K Short-term sleep deprivation may alter the dynamics of hippocampal cell proliferation in adult rats. Neuroscience 2010 170 1140 1152 20727388
47 Gould E Tanapat P Stress and hippocampal neurogenesis. Biol Psychiatry 1999 46 1472 1479 10599477
48 Duman RS Malberg J Nakagawa S Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 2001 299 401 407 11602648
49 Spitzer NC Neurotransmitter Switching? No Surprise. Neuron 2015 86 1131 1144 26050033
50 Dulcis D Jamshidi P Leutgeb S Spitzer NC Neurotransmitter switching in the adult brain regulates behavior. Science 2013 340 449 453 23620046
51 Nakatomi H Kuriu T Okabe S Yamamoto S Hatano O Kawahara N Tamura A Kirino T Nakafuku M Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002 110 429 441 12202033
52 Sun D Endogenous neurogenic cell response in the mature mammalian brain following traumatic injury. Exp Neurol 2015
53 Sirko S Behrendt G Johansson PA Tripathi P Costa M Bek S Heinrich C Tiedt S Colak D Dichgans M Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected]. Cell Stem Cell 2013 12 426 439 23561443
54 Duan CL Liu CW Shen SW Yu Z Mo JL Chen XH Sun FY Striatal astrocytes transdifferentiate into functional mature neurons following ischemic brain injury. Glia 2015 63 1660 1670 26031629
55 Faiz M Sachewsky N Gascon S Bang KW Morshead CM Nagy A Adult Neural Stem Cells from the Subventricular Zone Give Rise to Reactive Astrocytes in the Cortex after Stroke. Cell Stem Cell 2015 17 624 634 26456685
56 Magnusson JP Goritz C Tatarishvili J Dias DO Smith EM Lindvall O Kokaia Z Frisen J A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse. Science 2014 346 237 241 25301628
57 Carlen M Meletis K Goritz C Darsalia V Evergren E Tanigaki K Amendola M Barnabe-Heider F Yeung MS Naldini L Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci 2009 12 259 267 19234458
58 Johansson CB Momma S Clarke DL Risling M Lendahl U Frisen J Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999 96 25 34 9989494
59 Sellers DL Maris DO Horner PJ Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury. J Neurosci 2009 29 6722 6733 19458241
60 Decimo I Bifari F Rodriguez FJ Malpeli G Dolci S Lavarini V Pretto S Vasquez S Sciancalepore M Montalbano A Nestin- and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction. Stem Cells 2011 29 2062 2076 22038821
61 Chi L Ke Y Luo C Li B Gozal D Kalyanaraman B Liu R Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells 2006 24 34 43 16099995
62 Danilov AI Covacu R Moe MC Langmoen IA Johansson CB Olsson T Brundin L Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis. Eur J Neurosci 2006 23 394 400 16420447
63 Meletis K Barnabe-Heider F Carlen M Evergren E Tomilin N Shupliakov O Frisen J Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol 2008 6 e182 18651793
64 Horky LL Galimi F Gage FH Horner PJ Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neurol 2006 498 525 538 16874803
65 Ohori Y Yamamoto S Nagao M Sugimori M Yamamoto N Nakamura K Nakafuku M Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J Neurosci 2006 26 11948 11960 17108169
66 Goritz C Dias DO Tomilin N Barbacid M Shupliakov O Frisen J A pericyte origin of spinal cord scar tissue. Science 2011 333 238 242 21737741
67 Albert MS DeKosky ST Dickson D Dubois B Feldman HH Fox NC Gamst A Holtzman DM Jagust WJ Petersen RC The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 7 270 279 21514249
68 McKhann GM Knopman DS Chertkow H Hyman BT Jack CR Jr. Kawas CH Klunk WE Koroshetz WJ Manly JJ Mayeux R The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 7 263 269 21514250
69 Winner B Winkler J Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol 2015 7 a021287 25833845
70 Rodriguez JJ Jones VC Tabuchi M Allan SM Knight EM LaFerla FM Oddo S Verkhratsky A Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS One 2008 3 e2935 18698410
71 Martinez-Canabal A Reconsidering hippocampal neurogenesis in Alzheimer's disease. Front Neurosci 2014 8 147 24966809
72 Li G Bien-Ly N Andrews-Zwilling Y Xu Q Bernardo A Ring K Halabisky B Deng C Mahley RW Huang Y GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 2009 5 634 645 19951691
73 Schinder AF Morgenstern NA Preview. Adult neurogenesis is altered by GABAergic imbalance in models of Alzheimer's disease. Cell Stem Cell 2009 5 573 574 19951683
74 Sun B Halabisky B Zhou Y Palop JJ Yu G Mucke L Gan L Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease. Cell Stem Cell 2009 5 624 633 19951690
75 Hardiman O van den Berg LH Kiernan MC Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011 7 639 649 21989247
76 Martin JB Gusella JF Huntington's disease. Pathogenesis and management. N Engl J Med 1986 315 1267 1276 2877396
77 Graveland GA Williams RS DiFiglia M Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985 227 770 773 3155875
78 Curtis MA Penney EB Pearson AG van Roon-Mom WM Butterworth NJ Dragunow M Connor B Faull RL Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A 2003 100 9023 9027 12853570
79 Curtis MA Penney EB Pearson J Dragunow M Connor B Faull RL The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience 2005 132 777 788 15837138
80 Phillips W Morton AJ Barker RA Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. J Neurosci 2005 25 11564 11576 16354914
81 Kohl Z Regensburger M Aigner R Kandasamy M Winner B Aigner L Winkler J Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease. BMC Neurosci 2010 11 114 20836877
82 Lazic SE Grote H Armstrong RJ Blakemore C Hannan AJ van Dellen A Barker RA Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport 2004 15 811 813 15073520
83 Gil JM Mohapel P Araujo IM Popovic N Li JY Brundin P Petersen A Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol Dis 2005 20 744 751 15951191
84 Compston A Coles A Multiple sclerosis. Lancet 2002 359 1221 1231 11955556
85 Compston A Coles A Multiple sclerosis. Lancet 2008 372 1502 1517 18970977
86 Olanow CW Tatton WG Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999 22 123 144 10202534
87 Lang AE Lozano AM Parkinson's disease. First of two parts. N Engl J Med 1998 339 1044 1053 9761807
88 Ziabreva I Ballard C Johnson M Larsen JP McKeith I Perry R Aarsland D Perry E Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathol Appl Neurobiol 2007 33 586 590 17573814
89 Hoglinger GU Rizk P Muriel MP Duyckaerts C Oertel WH Caille I Hirsch EC Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 2004 7 726 735 15195095
90 Le Grand JN Gonzalez-Cano L Pavlou MA Schwamborn JC Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression. Cell Mol Life Sci 2015 72 773 797 25403878
91 O'Keeffe GC Tyers P Aarsland D Dalley JW Barker RA Caldwell MA Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A 2009 106 8754 8759 19433789
92 Baker SA Baker KA Hagg T Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur J Neurosci 2004 20 575 579 15233767
93 Freundlieb N Francois C Tande D Oertel WH Hirsch EC Hoglinger GU Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci 2006 26 2321 2325 16495459
94 Winner B Geyer M Couillard-Despres S Aigner R Bogdahn U Aigner L Kuhn G Winkler J Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 2006 197 113 121 16246330
95 van den Berge SA van Strien ME Korecka JA Dijkstra AA Sluijs JA Kooijman L Eggers R De Filippis L Vescovi AL Verhaagen J The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain. Brain 2011 134 3249 3263 22075520
96 Pearce RK Hawkes CH Daniel SE The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995 10 283 287 7651444
97 Regensburger M Prots I Winner B Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity. Neural Plast 2014 2014 454696 25110593
98 Briggs R King TJ Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogsâ Eggs. Proc Natl Acad Sci U S A 1952 38 455 463 16589125
99 Gurdon JB Laskey RA The transplantation of nuclei from single cultured cells into enucleate frogsâ eggs. J Embryol Exp Morphol 1970 24 227 248 5531072
100 Wilmut I Schnieke AE McWhir J Kind AJ Campbell KH Viable offspring derived from fetal and adult mammalian cells. Nature 1997 385 810 813 9039911
101 Stevens LC The biology of teratomas. Adv Morphog 1967 6 1 31 4894128
102 Kleinsmith LJ Pierce GB Jr Multipotentiality of Single Embryonal Carcinoma Cells. Cancer Res 1964 24 1544 1551 14234000
103 Evans MJ Kaufman MH Establishment in culture of pluripotential cells from mouse embryos. Nature 1981 292 154 156 7242681
104 Thomson JA Itskovitz-Eldor J Shapiro SS Waknitz MA Swiergiel JJ Marshall VS Jones JM Embryonic stem cell lines derived from human blastocysts. Science 1998 282 1145 1147 9804556
105 Martin GR Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981 78 7634 7638 6950406
106 Gossler A Joyner AL Rossant J Skarnes WC Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science 1989 244 463 465 2497519
107 Brustle O Spiro AC Karram K Choudhary K Okabe S McKay RD In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci U S A 1997 94 14809 14814 9405695
108 Takahashi K Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 126 663 676 16904174
109 Park IH Zhao R West JA Yabuuchi A Huo H Ince TA Lerou PH Lensch MW Daley GQ Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008 451 141 146 18157115
110 Wernig M Meissner A Cassady JP Jaenisch R c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008 2 10 12 18371415
111 Kim JB Sebastiano V Wu G Arauzo-Bravo MJ Sasse P Gentile L Ko K Ruau D Ehrich M van den Boom D Oct4-induced pluripotency in adult neural stem cells. Cell 2009 136 411 419 19203577
112 Hou P Li Y Zhang X Liu C Guan J Li H Zhao T Ye J Yang W Liu K Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013 341 651 654 23868920
113 Hu BY Weick JP Yu J Ma LX Zhang XQ Thomson JA Zhang SC Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010 107 4335 4340 20160098
114 Boulting GL Kiskinis E Croft GF Amoroso MW Oakley DH Wainger BJ Williams DJ Kahler DJ Yamaki M Davidow L A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011 29 279 286 21293464
115 Delli Carri A Onorati M Lelos MJ Castiglioni V Faedo A Menon R Camnasio S Vuono R Spaiardi P Talpo F Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development 2013 140 301 312 23250204
116 Krencik R Weick JP Liu Y Zhang ZJ Zhang SC Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat Biotechnol 2011 29 528 534 21602806
117 Abad M Mosteiro L Pantoja C Canamero M Rayon T Ors I Grana O Megias D Dominguez O Martinez D Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 2013 502 340 345 24025773
118 Thier M Worsdorfer P Lakes YB Gorris R Herms S Opitz T Seiferling D Quandel T Hoffmann P Nothen MM Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012 10 473 479 22445518
119 Han DW Tapia N Hermann A Hemmer K Hoing S Arauzo-Bravo MJ Zaehres H Wu G Frank S Moritz S Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 2012 10 465 472 22445517
120 Lujan E Chanda S Ahlenius H Sudhof TC Wernig M Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci U S A 2012 109 2527 2532 22308465
121 Cheng L Hu W Qiu B Zhao J Yu Y Guan W Wang M Yang W Pei G Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res 2014 24 665 679 24638034
122 Ring KL Tong LM Balestra ME Javier R Andrews-Zwilling Y Li G Walker D Zhang WR Kreitzer AC Huang Y Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 2012 11 100 109 22683203
123 Niu W Zang T Zou Y Fang S Smith DK Bachoo R Zhang CL In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol 2013 15 1164 1175 24056302
124 Niu W Zang T Smith DK Vue TY Zou Y Bachoo R Johnson JE Zhang CL SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Reports 2015 4 780 794 25921813
125 Islam MM Smith DK Niu W Fang S Iqbal N Sun G Shi Y Zhang CL Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo Reprogramming. Stem Cell Reports 2015
126 Emborg ME Liu Y Xi J Zhang X Yin Y Lu J Joers V Swanson C Holden JE Zhang SC Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep 2013 3 646 650 23499447
127 Vierbuchen T Ostermeier A Pang ZP Kokubu Y Sudhof TC Wernig M Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010 463 1035 1041 20107439
128 Ambasudhan R Talantova M Coleman R Yuan X Zhu S Lipton SA Ding S Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 2011 9 113 118 21802386
129 Yoo AS Sun AX Li L Shcheglovitov A Portmann T Li Y Lee-Messer C Dolmetsch RE Tsien RW Crabtree GR MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011 476 228 231 21753754
130 Li X Zuo X Jing J Ma Y Wang J Liu D Zhu J Du X Xiong L Du Y Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons. Cell Stem Cell 2015 17 195 203 26253201
131 Hu W Qiu B Guan W Wang Q Wang M Li W Gao L Shen L Huang Y Xie G Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules. Cell Stem Cell 2015 17 204 212 26253202
132 Zhang L Yin JC Yeh H Ma NX Lee G Chen XA Wang Y Lin L Chen L Jin P Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons. Cell Stem Cell 2015 17 735 747 26481520
133 Liu ML Zang T Zou Y Chang JC Gibson JR Huber KM Zhang CL Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat Commun 2013 4 2183 23873306
134 Heinrich C Blum R Gascon S Masserdotti G Tripathi P Sanchez R Tiedt S Schroeder T Gotz M Berninger B Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol 2010 8 e1000373 20502524
135 Victor MB Richner M Hermanstyne TO Ransdell JL Sobieski C Deng PY Klyachko VA Nerbonne JM Yoo AS Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 2014 84 311 323 25374357
136 Pfisterer U Kirkeby A Torper O Wood J Nelander J Dufour A Bjorklund A Lindvall O Jakobsson J Parmar M Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011 108 10343 10348 21646515
137 Caiazzo M Dell'Anno MT Dvoretskova E Lazarevic D Taverna S Leo D Sotnikova TD Menegon A Roncaglia P Colciago G Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011 476 224 227 21725324
138 Kim J Su SC Wang H Cheng AW Cassady JP Lodato MA Lengner CJ Chung CY Dawlaty MM Tsai LH Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 2011 9 413 419 22019014
139 Liu X Li F Stubblefield EA Blanchard B Richards TL Larson GA He Y Huang Q Tan AC Zhang D Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res 2012 22 321 332 22105488
140 Addis RC Hsu FC Wright RL Dichter MA Coulter DA Gearhart JD Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One 2011 6 e28719 22174877
141 Son EY Ichida JK Wainger BJ Toma JS Rafuse VF Woolf CJ Eggan K Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 2011 9 205 218 21852222
142 Liu ML Zang T Zhang CL Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients. Cell Rep 2016 14 115 128 26725112
143 Torper O Pfisterer U Wolf DA Pereira M Lau S Jakobsson J Bjorklund A Grealish S Parmar M Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A 2013 110 7038 7043 23530235
144 Grande A Sumiyoshi K Lopez-Juarez A Howard J Sakthivel B Aronow B Campbell K Nakafuku M Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat Commun 2013 4 2373 23974433
145 Guo Z Zhang L Wu Z Chen Y Wang F Chen G In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell 2014 14 188 202 24360883
146 Heinrich C Bergami M Gascon S Lepier A Vigano F Dimou L Sutor B Berninger B Gotz M Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Reports 2014 3 1000 1014 25458895
147 Torper O Ottosson DR Pereira M Lau S Cardoso T Grealish S Parmar M In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry. Cell Rep 2015 12 474 481 26166567
148 Liu Y Miao Q Yuan J Han S Zhang P Li S Rao Z Zhao W Ye Q Geng J Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo. J Neurosci 2015 35 9336 9355 26109658
149 Rouaux C Arlotta P Fezf2 directs the differentiation of corticofugal neurons from striatal progenitors in vivo. Nat Neurosci 2010 13 1345 1347 20953195
150 De la Rossa A Bellone C Golding B Vitali I Moss J Toni N Luscher C Jabaudon D In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons. Nat Neurosci 2013 16 193 200 23292682
151 Wapinski OL Vierbuchen T Qu K Lee QY Chanda S Fuentes DR Giresi PG Ng YH Marro S Neff NF Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell 2013 155 621 635 24243019
152 Polo JM Anderssen E Walsh RM Schwarz BA Nefzger CM Lim SM Borkent M Apostolou E Alaei S Cloutier J A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012 151 1617 1632 23260147
153 Vierbuchen T Wernig M Direct lineage conversions: unnatural but useful? Nat Biotechnol 2011 29 892 907 21997635
154 Gore A Li Z Fung HL Young JE Agarwal S Antosiewicz-Bourget J Canto I Giorgetti A Israel MA Kiskinis E Somatic coding mutations in human induced pluripotent stem cells. Nature 2011 471 63 67 21368825
155 Rouaux C Arlotta P Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo. Nat Cell Biol 2013 15 214 221 23334497
